MOBILEYE GLOBAL INC-A (MBLY)

US60741F1049 - Common Stock

29.2  -1.7 (-5.5%)

After market: 29.17 -0.03 (-0.1%)

Fundamental Rating

5

Overall MBLY gets a fundamental rating of 5 out of 10. We evaluated MBLY against 42 industry peers in the Automobile Components industry. While MBLY has a great health rating, there are worries on its profitability. MBLY shows excellent growth, but is valued quite expensive already.



3

1. Profitability

1.1 Basic Checks

In the past year MBLY was profitable.
In the past year MBLY had a positive cash flow from operations.
In the past 5 years MBLY always reported negative net income.
Each year in the past 5 years MBLY had a positive operating cash flow.

1.2 Ratios

With a Return On Assets value of -0.17%, MBLY perfoms like the industry average, outperforming 42.86% of the companies in the same industry.
MBLY's Return On Equity of -0.18% is in line compared to the rest of the industry. MBLY outperforms 42.86% of its industry peers.
Industry RankSector Rank
ROA -0.17%
ROE -0.18%
ROIC N/A
ROA(3y)-0.38%
ROA(5y)N/A
ROE(3y)-0.4%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Looking at the Gross Margin, with a value of 50.36%, MBLY belongs to the top of the industry, outperforming 97.62% of the companies in the same industry.
In the last couple of years the Gross Margin of MBLY has grown nicely.
The Profit Margin and Operating Margin are not available for MBLY so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 50.36%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y9%
GM growth 5YN/A

8

2. Health

2.1 Basic Checks

MBLY does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for MBLY has been increased compared to 1 year ago.
There is no outstanding debt for MBLY. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

An Altman-Z score of 23.15 indicates that MBLY is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 23.15, MBLY belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
There is no outstanding debt for MBLY. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 23.15
ROIC/WACCN/A
WACC9.01%

2.3 Liquidity

A Current Ratio of 5.13 indicates that MBLY has no problem at all paying its short term obligations.
With an excellent Current ratio value of 5.13, MBLY belongs to the best of the industry, outperforming 92.86% of the companies in the same industry.
A Quick Ratio of 4.16 indicates that MBLY has no problem at all paying its short term obligations.
MBLY's Quick ratio of 4.16 is amongst the best of the industry. MBLY outperforms 90.48% of its industry peers.
Industry RankSector Rank
Current Ratio 5.13
Quick Ratio 4.16

8

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 70.88% over the past year.
The Revenue has grown by 11.24% in the past year. This is quite good.
The Revenue has been growing by 29.07% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)70.88%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q3.7%
Revenue 1Y (TTM)11.24%
Revenue growth 3Y29.07%
Revenue growth 5YN/A
Revenue growth Q2Q12.74%

3.2 Future

MBLY is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 32.64% yearly.
Based on estimates for the next years, MBLY will show a very strong growth in Revenue. The Revenue will grow by 33.15% on average per year.
EPS Next Y-50.3%
EPS Next 2Y-0.79%
EPS Next 3Y14.48%
EPS Next 5Y32.64%
Revenue Next Year-8.48%
Revenue Next 2Y12.88%
Revenue Next 3Y20.3%
Revenue Next 5Y33.15%

3.3 Evolution

The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.

1

4. Valuation

4.1 Price/Earnings Ratio

MBLY is valuated quite expensively with a Price/Earnings ratio of 36.05.
MBLY's Price/Earnings is on the same level as the industry average.
MBLY's Price/Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 24.92.
With a Price/Forward Earnings ratio of 72.53, MBLY can be considered very expensive at the moment.
Based on the Price/Forward Earnings ratio, MBLY is valued a bit more expensive than 66.67% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 21.49. MBLY is valued rather expensively when compared to this.
Industry RankSector Rank
PE 36.05
Fwd PE 72.53

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, MBLY is valued a bit more expensive than the industry average as 71.43% of the companies are valued more cheaply.
MBLY's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 79.53
EV/EBITDA 49.38

4.3 Compensation for Growth

A more expensive valuation may be justified as MBLY's earnings are expected to grow with 14.48% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-0.79%
EPS Next 3Y14.48%

0

5. Dividend

5.1 Amount

No dividends for MBLY!.
Industry RankSector Rank
Dividend Yield N/A

MOBILEYE GLOBAL INC-A

NASDAQ:MBLY (4/26/2024, 7:02:40 PM)

After market: 29.17 -0.03 (-0.1%)

29.2

-1.7 (-5.5%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobile Components
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap23.54B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 36.05
Fwd PE 72.53
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.17%
ROE -0.18%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 50.36%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.13
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 5.13
Quick Ratio 4.16
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)70.88%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y-50.3%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)11.24%
Revenue growth 3Y29.07%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y